US 11,544,335
Application 16/572,830 · Granted Jan 3, 2023
Propensity-driven search results
Estimated expiration
January 9, 2041
14y 53d remaining
Earliest effective filing
Sep 17, 2019
+ 20 years
Sep 17, 2039
PTA +480d
Jan 9, 2041
No TD
—
Final
Jan 9, 2041
- Earliest effective filing
- Sep 17, 2019
- + 20 years
- Sep 17, 2039
- PTA +480d
- Jan 9, 2041
- No TD
- —
- Final
- Jan 9, 2041
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- September 17, 2019
- Earliest effective filing
- September 17, 2019
- Issue date
- January 3, 2023
- PTA
- +480 days
- Base expiry (before PTA)
- September 17, 2039
September 17, 2019 + 20 years = September 17, 2039 + 480 PTA days = January 9, 2041
Continuity chain
No continuity chain; the patent’s own filing date was used.
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
You have the date. Your AI can have the file.
Application 16/572,830 · US 11,544,335
PatentReply compiles the prosecution history behind US 11,544,335: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11544335Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.